PLRX Pliant Therapeutics, Inc.

Fundamentals / CIK 0001746473 / USD

Pliant Therapeutics, Inc. reported $0 in revenue and a net loss of $90.36M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PLRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$78.44M$39.22M$0-$201.5MFY 2019 Revenue: $57.05MFY 2019 Net Income: -$631K2019FY 2020 Revenue: $41.82MFY 2020 Net Income: -$41.53M2020FY 2021 Revenue: $7.57MFY 2021 Net Income: -$97.26M2021FY 2022 Revenue: $9.69MFY 2022 Net Income: -$123.3M2022FY 2023 Revenue: $1.58MFY 2023 Net Income: -$161.3M2023FY 2024 Revenue: $0FY 2024 Net Income: -$210.3M2024FY 2025 Revenue: $0FY 2025 Net Income: -$149.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $1.58M $9.69M $7.57M $41.82M $57.05M
Research & Development $109.2M $169.3M $127.8M $96.94M $77.55M $66.19M $47.35M
Total Operating Expenses $156.4M $228.4M $185.7M $136.9M $105.1M $83.46M $58.28M
Operating Income -$156.4M -$228.4M -$184.1M -$127.2M -$97.53M -$41.65M -$1.23M
EBITDA -$154.7M -$226.2M -$182.3M -$125.4M -$96.00M -$40.34M -$118K
Interest Income -- -- -- -- -- $478K $816K
Interest Expense $2.56M $3.02M $1.27M $791K $0 -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$149.3M -$210.3M -$161.3M -$123.3M -$97.26M -$41.53M -$631K
Basic EPS -$2.43 -$3.47 -$2.75 -$2.94 -$2.71 -$1.95 -$4.22
Diluted EPS -$2.43 -$3.47 -$2.75 -$2.94 -$2.71 -$1.95 -$4.22
Basic Shares Outstanding 61.4M 60.5M 58.7M 42.0M 35.8M 21.3M 1.6M
Diluted Shares Outstanding 61.4M 60.5M 58.7M 42.0M 35.8M 21.3M 1.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $0
Research & Development $17.93M $16.73M $13.58M $15.59M $17.94M $32.20M $43.44M $38.79M
Total Operating Expenses $25.74M $23.86M $21.77M $23.58M $28.27M $45.59M $58.94M $53.32M
Operating Income -$25.74M -$23.86M -$21.77M -$23.58M -$28.27M -$45.59M -$58.94M -$53.32M
EBITDA -$25.54M -$23.66M -$21.51M -$23.21M -$27.87M -$45.19M -$58.49M -$52.86M
Interest Expense $0 $0 $0 $136K $815K $809K $799K $834K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$24.38M -$22.37M -$20.04M -$23.58M -$26.30M -$43.30M -$56.17M -$49.73M
Basic EPS -$0.39 -$0.36 -$0.32 -- -$0.43 -$0.71 -$0.92 --
Diluted EPS -$0.39 -$0.36 -$0.32 -- -$0.43 -$0.71 -$0.92 --
Basic Shares Outstanding 61.9M 61.9M 61.8M -- 61.4M 61.4M 61.2M --
Diluted Shares Outstanding 61.9M 61.9M 61.8M -- 61.4M 61.4M 61.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $45.45M $71.19M $63.23M $33.69M $51.66M $50.88M $85.81M
Short-Term Investments $145.5M $284.5M $431.0M $297.5M $148.9M $226.0M $16.97M
Cash & Short-Term Investments $190.9M $355.7M $494.2M $331.2M $200.6M $276.9M $102.8M
Accounts Receivable, Net -- -- $0 $1.98M $2.00M $9.28M $7.05M
Total Current Assets $196.4M $362.3M $505.5M $340.3M $209.4M $290.8M $111.9M
Property, Plant & Equipment, Net $2.94M $5.53M $3.57M $4.49M $4.61M $4.32M $4.08M
Other Non-Current Assets $392K $435K $392K $394K $838K $451K $3.08M
Total Non-Current Assets $28.78M $34.69M $6.65M $10.30M $11.77M $4.77M $7.16M
Total Assets $225.2M $396.9M $512.2M $350.6M $221.2M $295.5M $119.1M
Accounts Payable $480K $5.96M $4.53M $1.58M $2.97M $2.02M $1.25M
Total Current Liabilities $16.36M $33.22M $28.52M $23.91M $16.83M $11.60M $8.17M
Long-Term Debt $0 $30.21M $10.05M $9.93M $0 -- --
Other Non-Current Liabilities -- -- -- -- $0 $866K $912K
Total Non-Current Liabilities $27.66M $59.65M $10.05M $13.36M $5.33M $866K $912K
Total Liabilities $44.02M $92.87M $38.58M $37.27M $22.16M $12.46M $9.08M
Total Debt (incl. Leases) $29.11M $60.19M $11.37M $15.81M $7.19M -- --
Common Stock $6.0K $6.0K $6.0K $5.0K $3.0K $3.0K $1.0K
Retained Earnings -$859.4M -$710.1M -$499.7M -$338.4M -$215.1M -$117.8M -$76.30M
Accumulated Other Comp. Income -$15K $321K $345K -$1.96M -$201K -$32K -$1.0K
Total Stockholders' Equity $181.2M $304.1M $473.6M $313.3M $199.1M $283.1M -$76.30M
Total Equity $181.2M $304.1M $473.6M $313.3M $199.1M $283.1M -$76.30M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $26.57M $24.88M $22.19M $45.45M $93.73M $86.82M $91.94M $71.19M
Short-Term Investments $114.5M $133.2M $148.7M $145.5M $148.1M $176.1M $213.7M $284.5M
Cash & Short-Term Investments $141.1M $158.1M $170.9M $190.9M $241.8M $262.9M $305.6M $355.7M
Total Current Assets $144.2M $163.1M $174.9M $196.4M $245.6M $267.4M $311.2M $362.3M
Property, Plant & Equipment, Net $2.18M $2.41M $2.66M $2.94M $4.34M $4.89M $5.24M $5.53M
Other Non-Current Assets $568K $554K $389K $392K $392K $391K $427K $435K
Total Non-Current Assets $25.67M $26.74M $27.67M $28.78M $31.01M $32.38M $33.58M $34.69M
Total Assets $169.9M $189.9M $202.6M $225.2M $276.6M $299.8M $344.8M $396.9M
Accounts Payable $3.07M $1.53M $362K $480K $485K $1.38M $5.62M $5.96M
Total Current Liabilities $17.92M $16.48M $10.36M $16.36M $17.62M $20.59M $28.20M $33.22M
Long-Term Debt $0 $0 $0 $0 $30.44M $30.36M $30.28M $30.21M
Total Non-Current Liabilities $25.32M $26.47M $27.07M $27.66M $58.67M $59.15M $59.40M $59.65M
Total Liabilities $43.24M $42.95M $37.43M $44.02M $76.29M $79.74M $87.61M $92.87M
Total Debt (incl. Leases) $27.78M $28.74M $28.78M $29.11M $59.86M $60.38M $60.17M $60.19M
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$926.2M -$901.8M -$879.4M -$859.4M -$835.8M -$809.5M -$766.2M -$710.1M
Accumulated Other Comp. Income -$530K -$397K -$341K -$15K $34K -$1.0K $159K $321K
Total Stockholders' Equity $126.6M $146.9M $165.2M $181.2M $200.3M $220.1M $257.2M $304.1M
Total Equity $126.6M $146.9M $165.2M $181.2M $200.3M $220.1M $257.2M $304.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$149.3M -$210.3M -$161.3M -$123.3M -$97.26M -$41.53M -$631K
Depreciation & Amortization $1.70M $2.12M $1.84M $1.82M $1.53M $1.31M $1.11M
Stock-Based Compensation $26.23M $37.63M $44.48M $22.60M $10.44M $3.90M $1.83M
Change in Receivables -- $0 $1.98M $15K $7.28M -$2.23M -$7.05M
Change in Payables -$5.48M $1.43M $2.97M -$1.35M $891K $922K -$1.25M
Operating Cash Flow -$128.3M -$155.5M -$116.4M -$94.63M -$75.44M -$37.27M -$2.75M
Capital Expenditure -$374K -$3.85M -$921K -$1.76M -$1.95M -$1.53M -$964K
Free Cash Flow -$128.7M -$159.4M -$117.3M -$96.39M -$77.40M -$38.80M -$3.71M
Investing Cash Flow $134.3M $140.3M -$127.0M -$150.2M $73.70M -$210.9M -$17.93M
Financing Cash Flow -$31.70M $23.12M $274.4M $226.9M $2.53M $213.2M $45.54M
Net Change in Cash -$25.74M $7.95M $31.03M -$17.98M $783K -$34.92M $24.86M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.38M -$22.37M -$20.04M -$23.58M -$26.30M -$43.30M -$56.17M -$49.73M
Depreciation & Amortization $200K $200K $264K $365K $400K $400K $448K $458K
Stock-Based Compensation $4.15M $4.19M $4.25M $4.53M $6.42M $6.38M $8.91M $8.42M
Change in Receivables -- -- -- -- -- -- -- $0
Change in Payables $1.54M $1.17M -$118K -$3.0K -$897K -$4.24M -$338K -$930K
Operating Cash Flow -$16.98M -$12.80M -$19.23M -$17.79M -$21.08M -$40.60M -$48.86M -$47.66M
Capital Expenditure $0 $0 $0 $0 $0 -$112K -$262K -$209K
Free Cash Flow -$16.98M -$12.80M -$19.23M -$17.79M -$21.08M -$40.72M -$49.13M -$47.87M
Investing Cash Flow $18.60M $15.49M -$4.10M $1.77M $27.92M $35.49M $69.11M $39.13M
Financing Cash Flow $64K $0 $74K -$32.27M $72K $0 $498K $102K
Net Change in Cash $1.69M $2.69M -$23.25M -$48.29M $6.91M -$5.12M $20.75M -$8.43M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -11654.7% -1313.4% -1288.1% -99.6% -2.2%
Net Profit Margin -- -- -10211.1% -1273.3% -1284.5% -99.3% -1.1%
Return on Equity (ROE) -82.4% -69.2% -34.1% -39.4% -48.9% -14.7% --
Return on Assets (ROA) -66.3% -53.0% -31.5% -35.2% -44.0% -14.1% -0.5%
Current Ratio 12.00x 10.91x 17.72x 14.23x 12.44x 25.07x 13.69x
Quick Ratio 11.67x 10.71x 17.33x 13.93x 12.04x 24.67x 13.44x
Debt to Equity 0.16x 0.20x 0.02x 0.05x 0.04x -- --
Revenue Growth (YoY) -- -100.0% -83.7% +27.9% -81.9% -26.7% --
5Y Revenue / Share Growth -100.0% -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -71.4% -62.8% -68.5% -82.4% -87.6% -94.0% -85.4% -69.2%
Return on Assets (ROA) -53.2% -48.6% -55.9% -66.3% -63.4% -69.0% -63.7% -53.0%
Current Ratio 8.05x 9.90x 16.89x 12.00x 13.93x 12.99x 11.03x 10.91x
Quick Ratio 7.87x 9.59x 16.50x 11.67x 13.72x 12.77x 10.84x 10.71x
Debt to Equity 0.22x 0.20x 0.17x 0.16x 0.30x 0.27x 0.23x 0.20x
Source: SEC EDGAR CompanyFacts (CIK 0001746473) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal